Article Versions Notes

Karagianni F, Piperi C, Casar B, de la Fuente-Vivas D, García-Gómez R, Lampadaki K, Pappa V, Papadavid E. Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma. Cancers. 2022; 14(4):1070. https://doi.org/10.3390/cancers14041070

Karagianni, Fani, Christina Piperi, Berta Casar, Dalia de la Fuente-Vivas, Rocío García-Gómez, Kyriaki Lampadaki, Vasiliki Pappa, and Evangelia Papadavid. 2022. "Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma" Cancers 14, no. 4: 1070. https://doi.org/10.3390/cancers14041070

Karagianni, F., Piperi, C., Casar, B., de la Fuente-Vivas, D., García-Gómez, R., Lampadaki, K., Pappa, V., & Papadavid, E. (2022). Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma. Cancers, 14(4), 1070. https://doi.org/10.3390/cancers14041070